Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/11/1997 | WO1997046105A1 Method of controlling insect pests |
12/11/1997 | WO1997046100A1 Serpin enzyme complex receptor-mediated gene transfer |
12/11/1997 | WO1997046079A1 Seed plants exhibiting inducible early reproductive development and methods of making same |
12/11/1997 | WO1997046078A1 Maize and cauliflower apetala1 gene products and nucleic acid molecules encoding same |
12/11/1997 | WO1997046077A1 Seed plants exhibiting early reproductive development and methods of making same |
12/11/1997 | WO1997041443A3 Method for screening compounds |
12/11/1997 | WO1997041256A3 Method and reagent for detecting multiple nucleic acid sequences in a test sample |
12/11/1997 | WO1997041252A3 Dna, rna and a protein useful for detection of a mycobacterial infection |
12/11/1997 | WO1997041228A3 Use of the green fluorescent protein as a screenable marker for plant transformation |
12/11/1997 | WO1997038082A3 Hypertonia gene |
12/11/1997 | WO1997035967A3 Transgenic organisms with altered telomerase activity |
12/11/1997 | WO1997029319A3 Bioluminescent novelty items |
12/11/1997 | WO1997022700A3 Grapevine leafroll virus proteins and their uses |
12/11/1997 | DE19622840A1 Continuous liquid phase reaction with heterogeneous catalyst in a pulsed column |
12/11/1997 | DE19622783A1 Isolierung der Biosynthesegene für Pseudo-Oligosaccharide aus Streptomyces glaucescens GLA.O und ihre Verwendung Isolation of the biosynthetic genes for pseudo-oligosaccharides from Streptomyces glaucescens GLA.O and their use |
12/11/1997 | CA2258720A1 Human thyrotropin receptor compositions and use thereof |
12/11/1997 | CA2257943A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
12/11/1997 | CA2257531A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides |
12/11/1997 | CA2257389A1 Virus-like particles useful as a vector for delivering nucleic acid |
12/11/1997 | CA2257243A1 Polynucleotides from human adult pbmc encoding secreted proteins |
12/11/1997 | CA2257240A1 Fragments of leptin (ob protein) |
12/11/1997 | CA2257182A1 Nucleotide probes and method for determining hla dqb1 typing |
12/11/1997 | CA2257149A1 Nematode-inducible plant gene promoter |
12/11/1997 | CA2257135A1 Nucleic acid primers and probes for detecting chlamydia pneumoniae |
12/11/1997 | CA2257119A1 Exendin analogues, processes for their production and pharmaceutical preparations containing them |
12/11/1997 | CA2257117A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof |
12/11/1997 | CA2257096A1 Integration cassette for improvement of transgenesis in eukaryotes |
12/11/1997 | CA2256765A1 2'-substituted nucleosides and oligonucleotide derivatives |
12/11/1997 | CA2256700A1 Sequencing by ligation of encoded adaptors |
12/11/1997 | CA2256558A1 Serpin enzyme complex receptor-mediated gene transfer |
12/11/1997 | CA2256523A1 Galanin receptor galr2 |
12/11/1997 | CA2256522A1 Polynucleotides encoding secreted proteins |
12/11/1997 | CA2256520A1 Polynucleotides encoding secreted proteins from human dendritic cells |
12/11/1997 | CA2256484A1 Vectors comprising sar elements |
12/11/1997 | CA2256464A1 Tumor necrosis factor-related polypeptide |
12/11/1997 | CA2256456A1 Enhanced efficacy of liposomal antisense delivery |
12/11/1997 | CA2256304A1 Cellular internalization of pigr stalk and associated ligands |
12/11/1997 | CA2254862A1 Metabotropic gaba[b] receptors, receptor-specific ligands and their uses |
12/11/1997 | CA2254819A1 Inhibition of hiv-1 replication by antisense rna expression |
12/11/1997 | CA2253262A1 Transgenic animals expressing artificial epitope-tagged proteins |
12/11/1997 | CA2229017A1 Optimally fluorescent oligonucleotides |
12/11/1997 | CA2228444A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
12/11/1997 | CA2228301A1 Materials and methods for detection of breast cancer |
12/11/1997 | CA2208315A1 Method of selection of allelic exchange mutants |
12/10/1997 | EP0811696A2 Method to obtain nucleotide sequence using randomly primed amplification |
12/10/1997 | EP0811695A2 Mutant S182(PS-1) genes |
12/10/1997 | EP0811688A2 Staphylococcus aureus RNase P |
12/10/1997 | EP0811687A2 Polypeptides having l-asparaginase activity |
12/10/1997 | EP0811686A2 Human platelet-derived growth factor receptors |
12/10/1997 | EP0811685A2 Human platelet-derived growth factor receptors |
12/10/1997 | EP0811684A2 Oxytocin receptor portion or variant, and dna coding for the same |
12/10/1997 | EP0811683A1 Antibodies to human gastrin-releasing peptide precursor and use thereof |
12/10/1997 | EP0811682A2 Method of producing L-lysine |
12/10/1997 | EP0811385A2 Conjugate of a factor specifically recognizing interleukin-2 receptor with ribonuclease |
12/10/1997 | EP0811160A1 Nf-kappa b activation regulatory protein, i-kappa b-beta |
12/10/1997 | EP0811079A2 Early recognition process of hpv-associated carcinomas or high-grade, hpv-caused dysplasias |
12/10/1997 | EP0811078A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth |
12/10/1997 | EP0811077A1 A rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation |
12/10/1997 | EP0811076A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF |
12/10/1997 | EP0811074A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
12/10/1997 | EP0811073A2 Methods and compositions for administering gene therapy vectors |
12/10/1997 | EP0811072A1 Transgenic animals as model of psoriasis |
12/10/1997 | EP0811071A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
12/10/1997 | EP0811070A1 Method to obtain male-sterile plants |
12/10/1997 | EP0811069A1 Chimeric adenoviral fiber protein and methods of using same |
12/10/1997 | EP0811068A1 HUMAN DNase I VARIANTS |
12/10/1997 | EP0811067A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
12/10/1997 | EP0811066A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
12/10/1997 | EP0811065A1 Antagonists of interleukin-15 |
12/10/1997 | EP0811064A2 Mpl ligand analogs |
12/10/1997 | EP0811063A2 Chemokine receptors 88-2b ckr-3] and 88c and their antibodies |
12/10/1997 | EP0811062A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof |
12/10/1997 | EP0811061A1 Multiple-tumor aberrant growth genes |
12/10/1997 | EP0811060A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS |
12/10/1997 | EP0811059A1 Human chemokine beta-11 and human chemokine alpha-1 |
12/10/1997 | EP0811057A1 Viral preparations, vectors, immunogens, and vaccines |
12/10/1997 | EP0811015A1 Immunoassay using antibodies directed to the reaction product of enzymes used as labels |
12/10/1997 | EP0811014A1 Novel bacteriocin piscicolin 126 |
12/10/1997 | EP0811013A1 Isolated nonapeptides presented by hla molecules, and uses thereof |
12/10/1997 | EP0810882A1 Methods and compositions for regulation of cd28 expression |
12/10/1997 | EP0810881A1 Delivery of therapeutic agents by gene therapy |
12/10/1997 | EP0810878A2 Rna photocleavage using texaphyrins |
12/10/1997 | EP0810874A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
12/10/1997 | EP0638122B1 Cdna sequence of dengue virus serotype 1 (singapore strain) |
12/10/1997 | EP0610246B1 Novel thrombin-inhibiting protein from ticks |
12/10/1997 | EP0567503B1 Pasteurella haemolytica glycoprotease gene |
12/10/1997 | EP0497878B1 Method for producing secretable glycosyltransferases |
12/10/1997 | EP0471687B1 Methods and nucleic acid sequences for the expression of the cellulose synthase operon |
12/10/1997 | EP0440744B1 Products and methods for controlling the suppression of the neoplastic phenotype |
12/10/1997 | CN1167505A Tie-2 ligands, methods of making and uses thereof |
12/10/1997 | CN1167504A Tetracycline-regulated transcriptional modulators |
12/10/1997 | CN1167503A An enzyme with lipolytic activity |
12/10/1997 | CN1167502A 人dna连接酶iii Human ligase iii dna |
12/10/1997 | CN1167490A Human stanniocalcin-alpha |
12/10/1997 | CN1167155A Method for cleaving chimeric protein using processing enzyme |
12/10/1997 | CN1167154A Amidase gene and modifying application of its expressed active products to polypeptide amidating |
12/10/1997 | CN1167153A Coversion of ginkgo rooting and establishment of clone |
12/10/1997 | CN1167152A Method for culturing microorganisms having methanol metabolic pathway |
12/10/1997 | CN1167151A Method for deciding relative translation initial rate of external source genes in colibacillus |
12/10/1997 | CN1167150A Method for production of recombining human grunulocyte colony stimulation factor |